MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

PHIT-Brain Study Protocol: Adaptation and Evaluation of a Multifaceted Brain Health Intervention for Patients with Parkinson’s Disease and Mild Cognitive Impairment (PD-MCI)

G. Roth, D. Gonzalez (Chicago, USA)

Meeting: 2025 International Congress

Keywords: Cognitive dysfunction, Memory disorders, Parkinson’s

Category: Parkinson's Disease (Other)

Objective: The aim is to adapt a brain health program for the PD population, the Parkinson’s Health Initiative for Thinking and the Brain (PHIT Brain), and determine feasibility and efficacy in PD-MCI patients.

Background: Approximately 80% of PD patients will experience cognitive impairment. About 15% have MCI at the time of diagnosis, and 20-57% develop MCI within 5 years of diagnosis. Research supports the use of cognitive rehabilitation strategies, specifically compensatory strategies for memory and executive functioning difficulties, in MCI. Additionally, exercise, nutrition, social engagement, mental health, and healthy sleep have been identified as modifiable factors that promote brain health and are beneficial treatment targets in PD. As such, an integrative approach is relevant for holistically addressing health and functioning in PD.

Method: PHIT Brain is a 9-week intervention program where participants and their care partner learn about cognitive rehabilitation techniques (particularly for memory and executive functioning), brain healthy behaviors (exercise, nutrition, sleep), and goal-attainment strategies to incorporate these habits into a daily routine. A nonrandomized, uncontrolled pre-post design will be implemented with 30 participant/partner dyads (60 total individuals) with diagnosed PD-MCI according to neuropsychological evaluation. Individuals will attend weekly, 90-minute in-person sessions and complete a battery of questionnaires examining compensatory behavior, mood, cognition, social connection, physical activity, and quality of life/functioning at their baseline and final visit to evaluate pre- and post-treatment outcomes.

Results: The primary outcome of the study is use of cognitive compensatory strategies. Secondary outcomes include patient self-reported mood, cognitive complaints, social connection, quality of life/functioning, and physical activity. Recruitment of participants started in February 2025 and will continue until August 2025. Paired statistics (e.g., Wilcoxon signed-ranks, repeated measure ANCOVA) will be applied.

Conclusion: This intervention will provide insights on the adaptation, feasibility, and effectiveness of a multifaceted brain health program for supporting cognition, functioning, and quality of life in PD-MCI patients.

To cite this abstract in AMA style:

G. Roth, D. Gonzalez. PHIT-Brain Study Protocol: Adaptation and Evaluation of a Multifaceted Brain Health Intervention for Patients with Parkinson’s Disease and Mild Cognitive Impairment (PD-MCI) [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/phit-brain-study-protocol-adaptation-and-evaluation-of-a-multifaceted-brain-health-intervention-for-patients-with-parkinsons-disease-and-mild-cognitive-impairment-pd-mci/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/phit-brain-study-protocol-adaptation-and-evaluation-of-a-multifaceted-brain-health-intervention-for-patients-with-parkinsons-disease-and-mild-cognitive-impairment-pd-mci/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley